1)Yardly L:Overview of psychologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am 33:603-616, 2000
2)Afzelius LE, et al:Vertigo and dizziness of functional origin. Laryngoscope 90:649-656, 1980
3)日本心身医学会教育研修委員会(編):心身医学の新しい診療指針.心身医 31:537-576,1991
4)中川哲也:心身医学の歴史.新心身医学,末松弘行(編).朝倉書店,東京,1994,pp10-13
5)Sifneos PE:The prevelence of“Alexithymic”characteristics in psychosomatic patients. Psychother Psychosom 22:225-262, 1973
6)竹内尚子(監):薬剤便覧・増補1版.国際医学出版,東京,2008
7)浦部昌夫・他(編):今日の治療薬.南江堂,東京,2011,pp848-867
. Eur J Pharmacol 156:169-172 1988
receptors. J Psychopharmacol 16:253-260, 2002
10)Busto U, et al:Pharmacologic aspects of benzodiazepine tolerance and dependence. J Subse Abuse Treat 8:29-33, 1991
11)Kaufman J, et al:Comorbidity of mood and anxiety disorders. Depress Anxiety 12:69-76, 2000
12)村崎光邦:わが国における向精神薬の現状と展望,21世紀を目指して.臨床精神薬理 4:3-27,2001
13)田島 治:不安を伴ううつ病と不安障害に対するベンゾジアゼピンとSSRIの併用法.分子精神医学 3:42-51,2003
14)村上正人・他:私の処方箋・向精神薬の使い方.JOHNS 27:1287-1291,2011
15)Folmer RL, et al:SSRI use by tinnitus patients, Interactions between depression and tinnitus severity. Ear Nose Throat J 83:107-108, 2004
16)Christensen RC:Paroxetine in the treatment of tinnitus. Otolaryngol Head Neck Surg 125:436-438, 2001
17)五島史行・他:マレイン酸フルボキサミンを用いた耳鼻咽喉科領域の愁訴の治療.心療内科 10:238-242,2006
18)The American Psychiatric Association Task Force on Benzodiazepine Dependency:Benzodiazepine Dependence, Toxicity, and Abuse, A Task Force Report of the American Psychiatric Association. APA, Washington DC, 1990
19)The Royal College of Psychiatrists:CR59. Benzodiazepines:risks. Benefits and dependence A re-evaluation. Council Report CR 59 January 1997. Royal College of Psychiatrists, London, 1997